Antigen loss following CAR‐T cell therapy: Mechanisms, implications, and potential solutions
Abstract Chimeric Antigen Receptor T‐cell (CAR‐T cell) therapy has emerged as a
groundbreaking immunotherapeutic approach for treating various hematological …
groundbreaking immunotherapeutic approach for treating various hematological …
CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side …
P Ercilla-Rodríguez, M Sánchez-Díez… - Frontiers in …, 2024 - frontiersin.org
Immunotherapy has made significant strides in cancer treatment with strategies like
checkpoint blockade antibodies and adoptive T cell transfer. Chimeric antigen receptor T …
checkpoint blockade antibodies and adoptive T cell transfer. Chimeric antigen receptor T …
Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer
JA Minott, JP van Vloten, JGE Yates, LA Santry… - Molecular Therapy …, 2023 - cell.com
Immunotherapies revive host immune responses against tumors by stimulating innate and
adaptive immune effector cells with anti-tumor functions. Thus, detailed studies of …
adaptive immune effector cells with anti-tumor functions. Thus, detailed studies of …